All insights
Importer handoffMarket-Ready Sales & SupportSource review as of 2026-07-02

FDA Medical Device Importer Requirements: What to Check Before Private-Label Launch

Before a private-label launch, check who is acting as manufacturer, foreign manufacturer, United States agent, initial importer, labeler, distributor, and complaint-contact owner. The practical output is an importer handoff checklist with source links, role assumptions, and unresolved reviewer questions.

FDA sources can explain registration, listing, initial importer, import, and Unique Device Identification (UDI) concepts. They cannot decide whether your role map is compliant, whether your label is acceptable, or whether the device may be legally marketed.

For one United States founder or commercial lead preparing a private-label imported device launch.

The private-label launch risk

Private-label teams often treat importer, labeler, distributor, complaint owner, and sales owner as business labels. FDA-facing role questions need a more exact map before launch.

The goal is not to decide the role in an article. The goal is to collect the right evidence and questions before the product moves through a distributor, listing, label, or sales handoff.

Role map to prepare

  • Foreign manufacturer and actual manufacturer relationship.
  • United States agent and initial importer assumptions.
  • Labeler, private-label brand owner, relabeler, repackager, or specification developer questions.
  • Distributor and final-delivery path.
  • Complaint intake, escalation, recall communication, and support ownership.

Evidence to collect before launch

Evidence itemWhy it mattersReviewer question
Registration and listing recordsThey help map who is visible in FDA-facing records.Do the records match the actual role and product flow?
Label and package identityPrivate-label wording can change role assumptions and claim boundaries.Who is the labeler and who approved the label?
UDI/GUDID informationDevice identifiers and GUDID records can be part of launch readiness.Who owns UDI data quality and updates?
Supplier market-status source claimsSupplier statements about clearance, exemption, listing, or pathway need source checks before sales use.What can the source show, what is only a supplier claim, and what requires qualified review?

Handoff checklist

  • Write one role map that separates manufacturer, importer, labeler, distributor, and support owner.
  • Attach source links for every role assumption.
  • List unresolved questions for regulatory, legal, quality, and operations review.
  • Define what sales and distributor teams may say, may not say, and must escalate.

What TrueMedDevice can prepare

TrueMedDevice can prepare the importer and private-label evidence packet: role map, source ledger, FDA public-record checks, UDI/GUDID question list, label handoff questions, distributor support boundary, and review-ready open questions.

The packet is preparation for qualified review. It is not an approval of importer, labeler, distributor, quality-system, labeling, or launch compliance.

Source ledger

FDA, Importing Medical Devices and Radiation-Emitting Electronic Products into the U.S.

What it can tell you

FDA import context, including that FDA verifies and enforces applicable requirements when a device is imported or offered for import.

What it cannot decide

Whether a specific shipment, private-label arrangement, label, or role map is admissible or compliant.

FDA, Who Must Register, List and Pay the Fee

What it can tell you

FDA role definitions and registration/listing context, including initial importer language.

What it cannot decide

Which role your company legally occupies or which obligations apply to your launch.

21 CFR Part 807, Establishment Registration and Device Listing

What it can tell you

Regulatory text for establishment registration and device listing, including initial importer provisions.

What it cannot decide

Your required filings, quality-system duties, labeling duties, or legal obligations without qualified review.

FDA, Global Unique Device Identification Database (GUDID)

What it can tell you

How the FDA-administered Global Unique Device Identification Database (GUDID) serves as a reference catalog for devices with unique device identifiers.

What it cannot decide

Whether your UDI data, labeler role, device identifier, packaging, or label content is complete or acceptable.

Frequently asked questions

Is an initial importer the same as a distributor?

Not always. FDA role definitions should be mapped to the actual flow of goods, labeling, ownership, and responsibilities, then reviewed by qualified regulatory or legal counsel.

Does a GUDID record prove the device can be sold?

No. GUDID is a device identification database record. It is not a complete market-authorization, labeling, importer, or compliance decision.

What should be ready before private-label sales launch?

A role map, source ledger, label and UDI question list, complaint-handoff plan, distributor claim boundaries, and open questions for qualified review.

Need the importer handoff before the first private-label sale?

Prepare the role map, source ledger, label questions, UDI questions, and distributor support boundaries before a partner starts selling from memory.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.
FDA Medical Device Importer Requirements Before Private-Label Launch | TrueMedDevice